Affera
Medical device company that developed cardiac mapping and ablation systems. Acquired by Medtronic in 2023.
Location
Newton, Massachusetts, USA
Founded
2016
Categories
medical-device, cardiac, electrophysiology, ablation, acquired
Notes
Affera was a medical device company focused on developing next-generation cardiac mapping and ablation technology for treating cardiac arrhythmias. The company developed the Sphere-9 catheter with integrated mapping and ablation capabilities, designed to simplify and improve the efficiency of cardiac ablation procedures.
Acquired by Medtronic in August 2023 for approximately $925 million, with potential for additional milestone payments. The acquisition expanded Medtronic's cardiac ablation solutions portfolio, particularly in pulsed field ablation (PFA) technology.
Team
- Zaya Tobia - Co-founder & Former CEO
- LinkedIn: linkedin.com/in/zayatobia
- David Packer - Co-founder & Chief Medical Officer
- Vivek Reddy, M.D. - Clinical Advisor
Additional Research Findings
- In Bain Capital Life Sciences portfolio (pre-acquisition)
- Sphere-9 catheter featured integrated high-density mapping and focal pulsed field ablation
- Technology designed to reduce procedure times and improve outcomes
- Received CE Mark approval for Sphere-9 system
- Acquisition by Medtronic closed August 2023 for ~$925 million upfront
- Technology now integrated into Medtronic's Cardiac Ablation Solutions business